Mogrify appoints Tom Graney as Non-Executive Director, Audit Chair and Capital Markets Advisor

Mogrify Limited (Mogrify), a biopharmaceutical company pioneering the development of a new class of in vivo reprogramming therapies and transforming the development of ex vivo cell therapies, today announced

Related Keywords

New York ,United States ,Lorenz Mayr ,Tom Graney ,Kostenloser Wertpapierhandel ,Michelle Ricketts ,Louise Modis ,Darrinm Disley ,Vertex Pharmaceuticals ,International Business ,Mogrify Limited ,Zyme Communications ,Ironwood Pharmaceuticals ,University Of Delaware ,Johnson ,Non Executive Director ,Audit Chair ,Capital Markets ,Jane Osbourn ,Generation Bio ,Vice President ,Chartered Financial Analyst ,Certified Financial Manager ,Management Accountant ,Mogrify ,Ppoints ,Ccraney ,Executive ,Director ,Audit ,Hair ,Capital ,Markets ,Advisor ,